Atossa Therapeutics ATOS
NASDAQ ATOS
$2.30 +0.03 (+1.31%)
As of: Oct 2, 2026 · 3:55 PM EDT

Atossa Therapeutics (ATOS) Depreciation & Amortization (CF) (2011 - 2026)

Updated

Atossa Therapeutics (ATOS) posted Depreciation & Amortization (CF) of $4,000 for Q2 2026, unchanged from $4,000 a year earlier and unchanged from the prior quarter.

Analysis

Atossa Therapeutics (ATOS) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Atossa Therapeutics was $16,000, unchanged year-over-year; for FY2025, it came in at $16,000, down 5.9% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of -19.4% (FY2020 to FY2025).
  • In prior years, Atossa Therapeutics' Depreciation & Amortization (CF) was $17,000 in FY2024 (-26.1%), $23,000 in FY2023 (+187.5%), $8,000 in FY2022 (-65.2%) and $23,000 in FY2021 (-51.1%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $2,000 in Q4 2021 to a high of $14,000 in Q4 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 7.3%.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 600.0%; the weakest was Q4 2021, with a decline of 79.5%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $4,000 (Q1 2026), $4,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Atossa Therapeutics 19.46 Mn 19.46 Mn - 4,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4,000.00
Mar 31, 2026 4,000.00
Dec 31, 2025 4,000.00
Sep 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 4,000.00
Mar 31, 2024 5,000.00
Dec 31, 2023 14,000.00
Sep 30, 2023 3,000.00
Jun 30, 2023 3,000.00
Mar 31, 2023 3,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 2,000.00
Jun 30, 2022 2,000.00
Mar 31, 2022 2,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 6,000.00
API Access

Atossa Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ATOS&period=max&api_key=YOUR_API_KEY